001     139142
005     20240321220549.0
024 7 _ |a 10.1093/brain/aww307
|2 doi
024 7 _ |a pmid:28137957
|2 pmid
024 7 _ |a pmc:PMC5278306
|2 pmc
024 7 _ |a 0006-8950
|2 ISSN
024 7 _ |a 1460-2156
|2 ISSN
024 7 _ |a altmetric:16092692
|2 altmetric
037 _ _ |a DZNE-2020-05464
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Estrada-Cuzcano, Alejandro
|b 0
245 _ _ |a Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
260 _ _ |a Oxford
|c 2017
|b Oxford Univ. Press
264 _ 1 |3 online
|2 Crossref
|b Oxford University Press (OUP)
|c 2017-01-30
264 _ 1 |3 print
|2 Crossref
|b Oxford University Press (OUP)
|c 2017-02-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1592813751_3872
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Hereditary spastic paraplegias are heterogeneous neurodegenerative disorders characterized by progressive spasticity of the lower limbs due to degeneration of the corticospinal motor neurons. In a Bulgarian family with three siblings affected by complicated hereditary spastic paraplegia, we performed whole exome sequencing and homozygosity mapping and identified a homozygous p.Thr512Ile (c.1535C > T) mutation in ATP13A2. Molecular defects in this gene have been causally associated with Kufor-Rakeb syndrome (#606693), an autosomal recessive form of juvenile-onset parkinsonism, and neuronal ceroid lipofuscinosis (#606693), a neurodegenerative disorder characterized by the intracellular accumulation of autofluorescent lipopigments. Further analysis of 795 index cases with hereditary spastic paraplegia and related disorders revealed two additional families carrying truncating biallelic mutations in ATP13A2. ATP13A2 is a lysosomal P5-type transport ATPase, the activity of which critically depends on catalytic autophosphorylation. Our biochemical and immunocytochemical experiments in COS-1 and HeLa cells and patient-derived fibroblasts demonstrated that the hereditary spastic paraplegia-associated mutations, similarly to the ones causing Kufor-Rakeb syndrome and neuronal ceroid lipofuscinosis, cause loss of ATP13A2 function due to transcript or protein instability and abnormal intracellular localization of the mutant proteins, ultimately impairing the lysosomal and mitochondrial function. Moreover, we provide the first biochemical evidence that disease-causing mutations can affect the catalytic autophosphorylation activity of ATP13A2. Our study adds complicated hereditary spastic paraplegia (SPG78) to the clinical continuum of ATP13A2-associated neurological disorders, which are commonly hallmarked by lysosomal and mitochondrial dysfunction. The disease presentation in our patients with hereditary spastic paraplegia was dominated by an adult-onset lower-limb predominant spastic paraparesis. Cognitive impairment was present in most of the cases and ranged from very mild deficits to advanced dementia with fronto-temporal characteristics. Nerve conduction studies revealed involvement of the peripheral motor and sensory nerves. Only one of five patients with hereditary spastic paraplegia showed clinical indication of extrapyramidal involvement in the form of subtle bradykinesia and slight resting tremor. Neuroimaging cranial investigations revealed pronounced vermian and hemispheric cerebellar atrophy. Notably, reduced striatal dopamine was apparent in the brain of one of the patients, who had no clinical signs or symptoms of extrapyramidal involvement.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a ATP13A2 protein, human
|2 NLM Chemicals
650 _ 7 |a Enzyme Inhibitors
|2 NLM Chemicals
650 _ 7 |a Leupeptins
|2 NLM Chemicals
650 _ 7 |a Proton-Translocating ATPases
|0 EC 3.6.3.14
|2 NLM Chemicals
650 _ 7 |a benzyloxycarbonylleucyl-leucyl-leucine aldehyde
|0 RF1P63GW3K
|2 NLM Chemicals
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Cells, Cultured: cytology
|2 MeSH
650 _ 2 |a Cells, Cultured: ultrastructure
|2 MeSH
650 _ 2 |a Chlorocebus aethiops
|2 MeSH
650 _ 2 |a Cognition Disorders: etiology
|2 MeSH
650 _ 2 |a Cognition Disorders: genetics
|2 MeSH
650 _ 2 |a Enzyme Inhibitors: pharmacology
|2 MeSH
650 _ 2 |a Family Health
|2 MeSH
650 _ 2 |a Gene Expression Regulation: drug effects
|2 MeSH
650 _ 2 |a Gene Expression Regulation: genetics
|2 MeSH
650 _ 2 |a Genetic Predisposition to Disease: genetics
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Leupeptins: pharmacology
|2 MeSH
650 _ 2 |a Lysosomes: drug effects
|2 MeSH
650 _ 2 |a Lysosomes: metabolism
|2 MeSH
650 _ 2 |a Lysosomes: ultrastructure
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Mental Disorders: etiology
|2 MeSH
650 _ 2 |a Mental Disorders: genetics
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mitochondria: drug effects
|2 MeSH
650 _ 2 |a Mitochondria: metabolism
|2 MeSH
650 _ 2 |a Mitochondria: ultrastructure
|2 MeSH
650 _ 2 |a Mutation: genetics
|2 MeSH
650 _ 2 |a Neuropsychological Tests
|2 MeSH
650 _ 2 |a Proton-Translocating ATPases: genetics
|2 MeSH
650 _ 2 |a Psychiatric Status Rating Scales
|2 MeSH
650 _ 2 |a Spastic Paraplegia, Hereditary: complications
|2 MeSH
650 _ 2 |a Spastic Paraplegia, Hereditary: diagnostic imaging
|2 MeSH
650 _ 2 |a Spastic Paraplegia, Hereditary: genetics
|2 MeSH
700 1 _ |a Martin, Shaun
|b 1
700 1 _ |a Chamova, Teodora
|b 2
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 3
|u dzne
700 1 _ |a Timmann, Dagmar
|b 4
700 1 _ |a Holemans, Tine
|b 5
700 1 _ |a Andreeva, Albena
|b 6
700 1 _ |a Reichbauer, Jennifer
|0 P:(DE-HGF)0
|b 7
700 1 _ |a De Rycke, Riet
|b 8
700 1 _ |a Chang, Dae-In
|b 9
700 1 _ |a van Veen, Sarah
|b 10
700 1 _ |a Samuel, Jean
|b 11
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 12
|u dzne
700 1 _ |a Pöppel, Thorsten
|b 13
700 1 _ |a Mollerup Sørensen, Danny
|b 14
700 1 _ |a Asselbergh, Bob
|b 15
700 1 _ |a Klein, Christine
|b 16
700 1 _ |a Zuchner, Stephan
|b 17
700 1 _ |a Jordanova, Albena
|0 P:(DE-HGF)0
|b 18
|e Corresponding author
700 1 _ |a Vangheluwe, Peter
|b 19
700 1 _ |a Tournev, Ivailo
|b 20
700 1 _ |a Schüle, Rebecca
|0 P:(DE-2719)2812018
|b 21
|e Last author
|u dzne
773 1 8 |a 10.1093/brain/aww307
|b : Oxford University Press (OUP), 2017-01-30
|n 2
|p 287-305
|3 journal-article
|2 Crossref
|t Brain
|v 140
|y 2017
|x 0006-8950
773 _ _ |a 10.1093/brain/aww307
|g Vol. 140, no. 2, p. 287 - 305
|0 PERI:(DE-600)1474117-9
|n 2
|q 140:2<287 - 305
|p 287-305
|t Brain
|v 140
|y 2017
|x 0006-8950
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278306
909 C O |o oai:pub.dzne.de:139142
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 12
|6 P:(DE-2719)2810795
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2812018
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|2 G:(DE-HGF)POF3-300
|v Population Studies and Genetics
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|2 G:(DE-HGF)POF3-300
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-09
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-09
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b BRAIN : 2021
|d 2022-11-09
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser 1
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls 1
|l Clinical Neurogenetics
|x 1
920 1 _ |0 I:(DE-2719)5000024
|k AG Maetzler
|l Functional Neurogeriatrics
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)5000024
980 _ _ |a UNRESTRICTED
999 C 5 |a 10.1038/nmeth0410-248
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nmeth0410-248
999 C 5 |a 10.1007/s00415-009-0083-3
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00415-009-0083-3
999 C 5 |a 10.1001/jamaneurol.2013.1174
|9 -- missing cx lookup --
|2 Crossref
|o 10.1001/jamaneurol.2013.1174
999 C 5 |a 10.1002/mds.22996
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.22996
999 C 5 |a 10.1093/hmg/dds089
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/hmg/dds089
999 C 5 |a 10.1016/S0092-8674(00)81203-9
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/S0092-8674(00)81203-9
999 C 5 |a 10.1172/JCI77598
|9 -- missing cx lookup --
|2 Crossref
|o 10.1172/JCI77598
999 C 5 |a 10.1002/ajmg.b.31214
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ajmg.b.31214
999 C 5 |a 10.1101/gr.3577405
|9 -- missing cx lookup --
|2 Crossref
|o 10.1101/gr.3577405
999 C 5 |a 10.1002/jnr.23112
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/jnr.23112
999 C 5 |a 10.1016/j.parkreldis.2010.10.011
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.parkreldis.2010.10.011
999 C 5 |a 10.1055/s-0034-1389161
|9 -- missing cx lookup --
|2 Crossref
|o 10.1055/s-0034-1389161
999 C 5 |a 10.1016/j.neurobiolaging.2011.11.012
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2011.11.012
999 C 5 |a 10.1073/pnas.1112368109
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.1112368109
999 C 5 |a 10.1212/01.wnl.0000260963.08711.08
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000260963.08711.08
999 C 5 |a 10.1002/mds.22728
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.22728
999 C 5 |a 10.1002/mds.26129
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.26129
999 C 5 |a 10.1016/j.nbd.2011.02.009
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.nbd.2011.02.009
999 C 5 |a 10.1016/j.neulet.2010.03.018
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neulet.2010.03.018
999 C 5 |a 10.1007/s00401-013-1115-8
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/s00401-013-1115-8
999 C 5 |a 10.1016/j.jns.2012.03.025
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.jns.2012.03.025
999 C 5 |a 10.1038/nature15393
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nature15393
999 C 5 |a 10.1038/ng.300
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.300
999 C 5 |a 10.1002/humu.22836
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/humu.22836
999 C 5 |a 10.1038/ejhg.2013.29
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ejhg.2013.29
999 C 5 |a 10.1093/nar/gku1071
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/gku1071
999 C 5 |a 10.1016/j.neurobiolaging.2011.12.035
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.neurobiolaging.2011.12.035
999 C 5 |a 10.1002/mds.23552
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.23552
999 C 5 |a 10.1016/j.nbd.2011.12.015
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.nbd.2011.12.015
999 C 5 |a 10.1086/339935
|9 -- missing cx lookup --
|2 Crossref
|o 10.1086/339935
999 C 5 |a 10.1212/WNL.0b013e3182556c05
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/WNL.0b013e3182556c05
999 C 5 |a 10.1212/NXG.0000000000000098
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/NXG.0000000000000098
999 C 5 |a 10.1073/pnas.1508220112
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.1508220112
999 C 5 |a 10.1038/gim.2015.139
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/gim.2015.139
999 C 5 |a 10.1002/mus.24980
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mus.24980
999 C 5 |a 10.1038/nprot.2015.053
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nprot.2015.053
999 C 5 |a 10.1093/nar/gkt1026
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/gkt1026
999 C 5 |a 10.1093/hmg/ddu099
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/hmg/ddu099
999 C 5 |a 10.1038/nprot.2009.86
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nprot.2009.86
999 C 5 |a 10.1093/bioinformatics/btp324
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/bioinformatics/btp324
999 C 5 |a 10.1016/j.expneurol.2014.06.011
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.expneurol.2014.06.011
999 C 5 |a 10.1080/15384101.2015.1093420
|9 -- missing cx lookup --
|2 Crossref
|o 10.1080/15384101.2015.1093420
999 C 5 |y 2016
|2 Crossref
|o Martin 2016
999 C 5 |y 1989
|2 Crossref
|o Maruyama 1989
999 C 5 |a 10.1074/jbc.274.36.25227
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.274.36.25227
999 C 5 |a 10.1101/gr.107524.110
|9 -- missing cx lookup --
|2 Crossref
|o 10.1101/gr.107524.110
999 C 5 |a 10.1002/mds.20800
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.20800
999 C 5 |a 10.1093/brain/awv320
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awv320
999 C 5 |a 10.1016/j.ajhg.2013.04.011
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2013.04.011
999 C 5 |a 10.1016/j.ajhg.2013.04.018
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2013.04.018
999 C 5 |a 10.1002/mds.26243
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.26243
999 C 5 |a 10.1093/hmg/ddt623
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/hmg/ddt623
999 C 5 |a 10.1002/humu.21527
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/humu.21527
999 C 5 |a 10.1038/ng937
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng937
999 C 5 |a 10.1016/j.ajhg.2013.04.013
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2013.04.013
999 C 5 |a 10.1016/j.bbrc.2011.11.016
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.bbrc.2011.11.016
999 C 5 |a 10.1385/CBB:46:3:303
|9 -- missing cx lookup --
|2 Crossref
|o 10.1385/CBB:46:3:303
999 C 5 |a 10.1371/journal.pone.0039942
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0039942
999 C 5 |a 10.1002/mds.22399
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.22399
999 C 5 |a 10.1038/ng1884
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng1884
999 C 5 |a 10.1093/hmg/ddr606
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/hmg/ddr606
999 C 5 |a 10.1002/acn3.64
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/acn3.64
999 C 5 |a 10.1038/nbt.2053
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nbt.2053
999 C 5 |a 10.1016/j.bbamem.2015.04.008
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.bbamem.2015.04.008
999 C 5 |a 10.1111/j.1552-6569.2008.00327.x
|9 -- missing cx lookup --
|2 Crossref
|o 10.1111/j.1552-6569.2008.00327.x
999 C 5 |a 10.1002/mds.23464
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.23464
999 C 5 |a 10.1016/j.bbrc.2009.03.151
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.bbrc.2009.03.151
999 C 5 |a 10.1038/nmeth.2089
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nmeth.2089
999 C 5 |y 2013
|2 Crossref
|o Schneider 2013
999 C 5 |a 10.1002/mds.22947
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.22947
999 C 5 |a 10.1212/01.wnl.0000228242.53336.90
|9 -- missing cx lookup --
|2 Crossref
|o 10.1212/01.wnl.0000228242.53336.90
999 C 5 |a 10.1002/ana.24611
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/ana.24611
999 C 5 |a 10.1093/hmg/ddt057
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/hmg/ddt057
999 C 5 |a 10.1016/j.ajhg.2012.10.017
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2012.10.017
999 C 5 |a 10.1038/nmeth.2890
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/nmeth.2890
999 C 5 |a 10.1093/nar/29.1.308
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/nar/29.1.308
999 C 5 |a 10.1074/jbc.M112.387191
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M112.387191
999 C 5 |a 10.1093/brain/awt326
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awt326
999 C 5 |a 10.1093/brain/aww079
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/aww079
999 C 5 |a 10.1074/jbc.M111.233874
|9 -- missing cx lookup --
|2 Crossref
|o 10.1074/jbc.M111.233874
999 C 5 |a 10.1016/j.ajhg.2012.11.001
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2012.11.001
999 C 5 |a 10.1007/BF00690197
|9 -- missing cx lookup --
|2 Crossref
|o 10.1007/BF00690197
999 C 5 |a 10.4161/auto.20256
|9 -- missing cx lookup --
|2 Crossref
|o 10.4161/auto.20256
999 C 5 |a 10.1523/JNEUROSCI.5575-11.2012
|9 -- missing cx lookup --
|2 Crossref
|o 10.1523/JNEUROSCI.5575-11.2012
999 C 5 |a 10.3389/fnmol.2014.00001
|9 -- missing cx lookup --
|2 Crossref
|o 10.3389/fnmol.2014.00001
999 C 5 |a 10.1073/pnas.0906797106
|9 -- missing cx lookup --
|2 Crossref
|o 10.1073/pnas.0906797106
999 C 5 |a 10.1093/brain/awt227
|9 -- missing cx lookup --
|2 Crossref
|o 10.1093/brain/awt227
999 C 5 |a 10.1016/j.mito.2010.07.006
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.mito.2010.07.006
999 C 5 |a 10.1371/journal.pone.0055526
|9 -- missing cx lookup --
|2 Crossref
|o 10.1371/journal.pone.0055526
999 C 5 |a 10.1038/ng.712
|9 -- missing cx lookup --
|2 Crossref
|o 10.1038/ng.712
999 C 5 |a 10.1016/j.ajhg.2011.07.002
|9 -- missing cx lookup --
|2 Crossref
|o 10.1016/j.ajhg.2011.07.002
999 C 5 |a 10.1002/mds.20511
|9 -- missing cx lookup --
|2 Crossref
|o 10.1002/mds.20511


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21